Prevention of diabetes development in those with the metabolic syndrome.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 17964911.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Metabolic syndrome is characterized by abnormal glucose levels, central obesity, hypertension, elevated triglycerides, and low HDL cholesterol. This article reviews available data regarding the impact of lifestyle modification and drug therapies on the progression to diabetes in high risk individuals, such as those with hypertension, dyslipidemia, obesity, and prediabetes. Lifestyle and pharmacological interventions may alter metabolic parameters and impact progression to diabetes. However, the cost-effectiveness of these interventions are unclear.
Medical subject headings
- Anti-Obesity Agents
- Diabetes Mellitus
- Exercise Therapy
- Metabolic Syndrome